Unituss Junior 60 mg/10 ml, syrup, 120 ml

Unituss Junior  is a drug in the form of a syrup containing the active substance levodropropizine, which has antitussive and antibronchospasm properties .

Unituss Junior effectively suppresses cough of various origins, such as cough associated with lung cancer, cough associated with upper and lower respiratory tract infections, or whooping cough.

If after 7 days of using the syrup there is no improvement or the patient feels worse, contact your doctor.

Symptomatic treatment of nonproductive (dry) cough.

The active substance of the drug is levodropropizine. 10 ml of syrup contains 60 mg of levodropropizine.

The other ingredients are: methyl parahydroxybenzoate (E 218), propyl parahydroxybenzoate (E 216), sucrose, strawberry flavour 502301T (propylene glycol (E 1520), flavourings), citric acid monohydrate (E 330), sodium hydroxide, purified water.

Use in children from 2 years of age:

• 10-20 kg: 3 ml of syrup 3 times a day.
• 20-30 kg: 5 ml of syrup 3 times a day.

Use in adults:

• 10 ml of syrup up to 3 times a day.

• Unituss Junior should be taken orally, 3 times a day at least 6 hours apart. The syrup bottle comes with a measuring cup that allows you to measure 3, 5 and 10 ml.
• Do not use Unituss Junior for longer than 7 days without consulting your doctor.
• Treatment should be continued until the cough subsides or as directed by the physician. In any case, if the cough does not subside after 7 days of treatment, it is recommended to discontinue use of the drug and consult a physician.
• It is important to remember that cough is a symptom of a disease and the disease that causes it must be recognized and then treated.
• Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. If you are not sure, ask your doctor or pharmacist.

• if you are allergic to the active substance or any of the other ingredients of this medicine,
• in people with abundant bronchial secretions and impaired function of the bronchial epithelium cilia (Kartagener syndrome, ciliary dyskinesia),
• in pregnant and breastfeeding women.